Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases-Reference-Cited by-同舟云学术

Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases

Published:2016-03 Issue:6 Volume:590 Page:716-725
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:FEBS Lett

Author:

Ferraz Maria J.¹,Marques André R. A.¹,Appelman Monique D.¹,Verhoek Marri²,Strijland Anneke¹,Mirzaian Mina²,Scheij Saskia¹,Ouairy Cécile M.³,Lahav Daniel³,Wisse Patrick³,Overkleeft Herman S.³,Boot Rolf G.²,Aerts Johannes M.¹²

Affiliation:

1. Department of Medical Biochemistry; Academic Medical Center; Amsterdam The Netherlands

2. Department of Medical Biochemistry; Leiden Institute of Chemistry; Leiden University; The Netherlands

3. Department of Bio-organic Synthesis; Leiden Institute of Chemistry; Leiden University; The Netherlands

Funder

ERC AdvG CHEMSPHING

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Reference43 articles.

1. Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses;Ferraz;Biochim Biophys Acta,2014

2. CCL18: a urinary marker of Gaucher cell burden in Gaucher patients;Boot;J Inherit Metab Dis,2006

3. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease;Hollak;J Clin Invest,1994

4. Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response;Dekker;Blood,2011

5. Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard;Mirzaian;Blood Cells Mol Dis,2015

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease;Translational Neurodegeneration;2024-09-12

2. Clinical and preclinical insights into high-dose ambroxol therapy for Gaucher disease type 2 and 3: A comprehensive systematic review;Molecular Genetics and Metabolism;2024-09

3. Infrared spectroscopy as a new approach for early Fabry disease screening: a pilot study;2024-08-26

4. Fabry nephropathy: a treatable cause of chronic kidney disease;Rare Disease and Orphan Drugs Journal;2024-07-11

5. Unraveling the diagnostic enigma: laboratory diagnosis of sphingolipid activator protein deficiencies;Journal of Laboratory and Precision Medicine;2024-07